SOX10 and myeloid sarcoma: Consequently, it has been proposed that SOX10-induced transdifferentiation toward an oligodendrocyte-phenotype may represent a strategy of interest toward the development of stem-cell based therapy in MS and neurodegenerative disorders (Mokhtarzadeh Khanghahi et al. 2018; Yavarpour‐Bali et al. 2020; Mozafari et al. 2020).